In the present study, we revealed that Grpel2 overexpression by AAV9-Grpel2 injection alleviated diabetes-induced mitochondrial morphological abnormalities and decreased oxidative stress levels in the diabetic heart in vivo. The gene discussed is GRPEL2; the disease is diabetes mellitus.